Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Sort descending Program Official
Request for Information (RFI): Opportunities and Challenges in Enabling and Advancing Precision Medicine Artificial Intelligence (AI) by Integrating Clinical Imaging with Multimodal Data NOT-RM-24-011 09/23/2024 Amanda Skarlupka, Ph.D.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-24-009 (R33 Clinical Trial Not Allowed) R33 Clinical Trial Not Allowed 10/02/2024 Guillermo Marquez, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-24-008 (R61 Clinical Trial Not Allowed) R61 Clinical Trial Not Allowed 10/02/2024 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-24-012 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 10/02/2024 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-24-014 (P50 Clinical Trial Optional) P50 Clinical Trial Optional 10/02/2024 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research RFA-CA-24-013 (U01 Clinical Trial Optional) U01 Clinical Trial Optional 10/02/2024 Guillermo Marquez, Ph.D.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research PAR-21-330 (U01 Clinical Trial Not Allowed) U01 Clinical Trial Not Allowed 10/12/2024 Claire Zhu, Ph.D.
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites RFA-CA-24-024 (UG1 Clinical Trial Required) UG1 Clinical Trial Required 11/01/2024 Eva Szabo, M.D.
Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) RFA-CA-24-025 (UG1 Clinical Trial Required) UG1 Clinical Trial Required 11/01/2024 Eva Szabo, M.D.
Notice of Intent to Publish a Funding Opportunity Announcement for NCI Research Specialist (Clinician Scientist) Award NOT-CA-24-070 (R50 Clinical Trial Not Allowed) R50 Clinical Trial Not Allowed 11/04/2024 Brandy Heckman-Stoddard, Ph.D., M.P.H.